PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
TTEK vs. ACA
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between TTEK and ACA is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.4

Performance

TTEK vs. ACA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tetra Tech, Inc. (TTEK) and Arcosa, Inc. (ACA). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%20.00%AugustSeptemberOctoberNovemberDecember2025
1.42%
3.63%
TTEK
ACA

Key characteristics

Sharpe Ratio

TTEK:

0.96

ACA:

0.68

Sortino Ratio

TTEK:

1.37

ACA:

1.11

Omega Ratio

TTEK:

1.22

ACA:

1.15

Calmar Ratio

TTEK:

1.26

ACA:

1.24

Martin Ratio

TTEK:

3.34

ACA:

3.64

Ulcer Index

TTEK:

8.16%

ACA:

6.11%

Daily Std Dev

TTEK:

28.32%

ACA:

32.49%

Max Drawdown

TTEK:

-77.90%

ACA:

-36.79%

Current Drawdown

TTEK:

-17.13%

ACA:

-13.84%

Fundamentals

Market Cap

TTEK:

$11.19B

ACA:

$4.69B

EPS

TTEK:

$1.23

ACA:

$2.63

PE Ratio

TTEK:

33.99

ACA:

36.55

PEG Ratio

TTEK:

2.23

ACA:

6.72

Total Revenue (TTM)

TTEK:

$3.97B

ACA:

$1.90B

Gross Profit (TTM)

TTEK:

$675.94M

ACA:

$386.30M

EBITDA (TTM)

TTEK:

$453.55M

ACA:

$289.70M

Returns By Period

In the year-to-date period, TTEK achieves a 4.94% return, which is significantly higher than ACA's -0.63% return.


TTEK

YTD

4.94%

1M

-0.55%

6M

1.42%

1Y

25.58%

5Y*

20.39%

10Y*

26.46%

ACA

YTD

-0.63%

1M

-11.92%

6M

3.63%

1Y

22.00%

5Y*

15.79%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

TTEK vs. ACA — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TTEK
The Risk-Adjusted Performance Rank of TTEK is 7878
Overall Rank
The Sharpe Ratio Rank of TTEK is 8080
Sharpe Ratio Rank
The Sortino Ratio Rank of TTEK is 7171
Sortino Ratio Rank
The Omega Ratio Rank of TTEK is 7676
Omega Ratio Rank
The Calmar Ratio Rank of TTEK is 8585
Calmar Ratio Rank
The Martin Ratio Rank of TTEK is 7777
Martin Ratio Rank

ACA
The Risk-Adjusted Performance Rank of ACA is 7474
Overall Rank
The Sharpe Ratio Rank of ACA is 7373
Sharpe Ratio Rank
The Sortino Ratio Rank of ACA is 6666
Sortino Ratio Rank
The Omega Ratio Rank of ACA is 6666
Omega Ratio Rank
The Calmar Ratio Rank of ACA is 8585
Calmar Ratio Rank
The Martin Ratio Rank of ACA is 7979
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

TTEK vs. ACA - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Tetra Tech, Inc. (TTEK) and Arcosa, Inc. (ACA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for TTEK, currently valued at 0.96, compared to the broader market-2.000.002.000.960.68
The chart of Sortino ratio for TTEK, currently valued at 1.37, compared to the broader market-4.00-2.000.002.004.001.371.11
The chart of Omega ratio for TTEK, currently valued at 1.22, compared to the broader market0.501.001.502.001.221.15
The chart of Calmar ratio for TTEK, currently valued at 1.26, compared to the broader market0.002.004.006.001.261.24
The chart of Martin ratio for TTEK, currently valued at 3.34, compared to the broader market0.0010.0020.003.343.64
TTEK
ACA

The current TTEK Sharpe Ratio is 0.96, which is higher than the ACA Sharpe Ratio of 0.68. The chart below compares the historical Sharpe Ratios of TTEK and ACA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.00AugustSeptemberOctoberNovemberDecember2025
0.96
0.68
TTEK
ACA

Dividends

TTEK vs. ACA - Dividend Comparison

TTEK's dividend yield for the trailing twelve months is around 1.10%, more than ACA's 0.16% yield.


TTM20242023202220212020201920182017201620152014
TTEK
Tetra Tech, Inc.
1.10%1.15%1.85%1.80%2.27%1.16%2.05%1.66%1.64%2.48%3.65%3.93%
ACA
Arcosa, Inc.
0.16%0.21%0.24%0.37%0.38%0.36%0.45%0.00%0.00%0.00%0.00%0.00%

Drawdowns

TTEK vs. ACA - Drawdown Comparison

The maximum TTEK drawdown since its inception was -77.90%, which is greater than ACA's maximum drawdown of -36.79%. Use the drawdown chart below to compare losses from any high point for TTEK and ACA. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-17.13%
-13.84%
TTEK
ACA

Volatility

TTEK vs. ACA - Volatility Comparison

The current volatility for Tetra Tech, Inc. (TTEK) is 5.21%, while Arcosa, Inc. (ACA) has a volatility of 8.76%. This indicates that TTEK experiences smaller price fluctuations and is considered to be less risky than ACA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%AugustSeptemberOctoberNovemberDecember2025
5.21%
8.76%
TTEK
ACA

Financials

TTEK vs. ACA - Financials Comparison

This section allows you to compare key financial metrics between Tetra Tech, Inc. and Arcosa, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab